Negative Impact of Intra-Operative Blood Transfusion on Survival Outcomes of Hepatocellular Carcinoma Patients
- PMID: 38685982
- PMCID: PMC11057630
- DOI: 10.2147/CMAR.S448629
Negative Impact of Intra-Operative Blood Transfusion on Survival Outcomes of Hepatocellular Carcinoma Patients
Abstract
Background: Studies have reported that blood transfusion may have an association with survival outcomes of cancer patients. This study was aimed at finding the effect of intra-operative blood transfusion on the prognosis of patients of hepatocellular carcinoma (HCC).
Methods: This was a retrospective study. HCC patients who underwent tumor resection from January 2013 to November 2018 at Harbin Medical University Cancer Hospital were included. The survival time of patients receiving or not receiving blood transfusion during the operation were compared.
Results: Of HCC patients, 21.1% (102/484) received intra-operative blood transfusion. After propensity score matching, 87 pairs of patients were included in the study. In the subset of patients with a tumor size of >4 cm, univariable analysis found that there were significant differences in recurrence-free survival (RFS; P=0.004) and overall survival (OS; P=0.028) between blood transfusion and non-blood transfusion groups. After multivariable Cox regression analysis, intra-operative blood transfusion was an independent risk factor for RFS (HR: 2.011, 95% CI: 1.146-3.529, P=0.015), but not for OS (HR: 1.862, 95% CI: 0.933-3.715, P=0.078) in the subset of patients with a tumor size of >4 cm.
Conclusion: Intra-operative blood transfusion was associated with worse RFS in HCC patients with a tumor size of >4 cm.
Keywords: hepatocellular carcinoma; intra-operative blood transfusion; overall survival; recurrence-free survival.
© 2024 Teng et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures




Similar articles
-
Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.J Hepatol. 2016 Mar;64(3):583-93. doi: 10.1016/j.jhep.2015.10.012. Epub 2015 Oct 24. J Hepatol. 2016. PMID: 26596543
-
Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.World J Surg. 2019 Nov;43(11):2894-2901. doi: 10.1007/s00268-019-05085-w. World J Surg. 2019. PMID: 31312946
-
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29262506 Chinese.
-
Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.Eur J Surg Oncol. 2021 Mar;47(3 Pt B):620-627. doi: 10.1016/j.ejso.2020.09.021. Epub 2020 Sep 21. Eur J Surg Oncol. 2021. PMID: 32988700
-
Intraoperative autologous transfusion and oncologic outcomes in liver transplantation for hepatocellular carcinoma: a propensity matched analysis.HPB (Oxford). 2022 Mar;24(3):379-385. doi: 10.1016/j.hpb.2021.06.433. Epub 2021 Jul 6. HPB (Oxford). 2022. PMID: 34294524 Review.
References
-
- Yamashita Y-I, Hayashi H, Imai K, et al. Perioperative allogeneic blood transfusion does not influence patient survival after hepatectomy for hepatocellular carcinoma: a propensity score matching analysis. World J Surgery. 2019;43(11):2894–2901. - PubMed
LinkOut - more resources
Full Text Sources